A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.

Bretylium compounds are pharmaceutical agents, primarily used in the treatment of life-threatening ventricular arrhythmias, that work by stabilizing the cardiac membrane and inhibiting the release of norepinephrine from sympathetic nerve endings.

A product of putrefaction. Poisonous.

An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.

Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.

A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.